[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@VanMorrisMD Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1296149160.png) @VanMorrisMD Van Morris, MD

Van Morris, MD posts on X about  the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1296149160/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1296149160/c:line/m:interactions.svg)

- X Week XXXXX +1,773%
- X Month XXXXXX +103%
- X Months XXXXXX +445%
- X Year XXXXXX +273%

### Mentions: X [#](/creator/twitter::1296149160/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1296149160/c:line/m:posts_active.svg)


### Followers: XXXXX [#](/creator/twitter::1296149160/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1296149160/c:line/m:followers.svg)

- X Week XXXXX +1.30%
- X Month XXXXX +2.50%
- X Months XXXXX +11%
- X Year XXXXX +15%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1296149160/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1296149160/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1296149160/influence)
---

**Social category influence**
[currencies](/list/currencies)  XX%

**Top accounts mentioned or mentioned by**
[@mdandersonnews](/creator/undefined) [@skopetz](/creator/undefined) [@michaeloverman](/creator/undefined) [@emerikosterlund](/creator/undefined) [@aparna1024](/creator/undefined) [@chiaracrem1](/creator/undefined) [@anwaarsaeed3](/creator/undefined)
### Top Social Posts [#](/creator/twitter::1296149160/posts)
---
Top posts by engagements in the last XX hours

"Excellent talk from @EmerikOsterlund presenting research on ctDNA clearance patterns from pts w/ CRC in @MDAndersonNews INTERCEPT. Historical precedent for spontaneous ctDNA clearance using WES approach will help inform future trial design Accompanied by insightful perspective from the always incredible @aparna1024 . #endcancer"  
[X Link](https://x.com/VanMorrisMD/status/1979905891789885670) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-19T13:42Z 2511 followers, 2324 engagements


"Does chemotherapy affect the biology of BRAF V600E mCRC when combined with encorafenib + ceruximab Answer appears to be YES Very intriguing translational finding showing that addition of chemo to E+C reduces development of acquired RAS MAP2K1 and other mutations that drive resistance to BRAF + EGFR blockade. Will use this data in counseling patients why we add chemo to E+C in this pt population. 👏 to BREAKWATER team for releasing translational data on their large XXX pt () analysis And congrats to the always amazing @skopetz for an incredible presentation- our @MDAndersonNews team remains so"  
[X Link](https://x.com/VanMorrisMD/status/1980167996027867399) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:03Z 2510 followers, 9125 engagements


"🤯 🤯 Fantastic analysis of AtezoTRIBE and AVETRIC trials utilizing AI to predict benefit from IO in pts w/ MSS CRC- its wild that this biomarker work can be done from a single archival H&E slide. This approach will improve feasibility to analyze biomarkers in large multi-center trials moving forward. Industry should take note 👏 to @ChiaraCrem1 and study team"  
[X Link](https://x.com/VanMorrisMD/status/1980179738032497001) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:50Z 2510 followers, 3212 engagements


"Interesting ph3 trial showing XXX month OS benefit with zanzalintinib+ atezolizumab vs rego in pts w/ treatment-ref MSS CRC- toxicity significant and excited to see more mature data in the future. Congrats to @AnwaarSaeed3 for leading this ph X trial"  
[X Link](https://x.com/VanMorrisMD/status/1980181159926521942) [@VanMorrisMD](/creator/x/VanMorrisMD) 2025-10-20T07:55Z 2510 followers, 5191 engagements